Enterprise Value
784.9M
Cash
577.3M
Avg Qtr Burn
-26.1M
Short % of Float
10.60%
Insider Ownership
6.68%
Institutional Own.
79.01%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bexotegrast (PLN-74809) Details Idiopathic pulmonary fibrosis | Phase 2b Initiation | |
Bexotegrast (PLN-74809) Details Primary sclerosing cholangitis Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 2a Data readout | |
Failed Discontinued |